SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001962738-24-000025
Filing Date
2024-05-15
Accepted
2024-05-15 06:50:28
Documents
3
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20240514x6k.htm 6-K 18237
2 EX-99 tmb-20240514xex99.htm EX-99 176597
3 GRAPHIC tmb-20240514xex99001.jpg GRAPHIC 9897
  Complete submission text file 0001962738-24-000025.txt   209907
Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Filer) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41666 | Film No.: 24947064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)